Assessment of palliative care needs in adults with blood cancer
- Conditions
- Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]Health Condition 2: C920- Acute myeloblastic leukemiaHealth Condition 3: C926- Acute myeloid leukemia with 11q23-abnormalityHealth Condition 4: C92A- Acute myeloid leukemia with multilineage dysplasiaHealth Condition 5: C925- Acute myelomonocytic leukemiaHealth Condition 6: C924- Acute promyelocytic leukemia
- Registration Number
- CTRI/2020/09/027761
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
1)Adult patients of age 18 years or above
2)Newly diagnosed patients with AML/ALL attending the Adult Haemato- Oncology Joint Clinic at Tata Memorial Hospital and those who have not received any prior cancer directed treatment
3)Planned and expected to receive induction chemotherapy with curative intent
4)Patient has been informed of diagnosis and treatment
5)Able to communicate in English/Marathi/Hindi/Bengali
6)Performance Score of less than or equal to 3 on Eastern Cooperative Oncology Group(ECOG) scale
7)Able to give a written informed consent
1)Patients who are upfront best supportive care and are planned for treatment with palliative intent
2)Patients with unstable medical conditions , oncological emergencies or psychiatric emergencies.
3)Any form of intellectual disability or cognitive impairment defined as a Mini Mental Status Examination Score less than 24.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary Outcomes: <br/ ><br>i)Identification of needs and major domains of needs in adult patients with AML/ALL using Functional Assessment of Cancer Therapy-Leukaemia(FACT- Leu) scale and subscales at baseline and at 4 weeks following induction chemotherapy. <br/ ><br>ii)To measure the symptom burden specific to this patient population using FACT- Leu subscales at baseline and at 4 weeks. <br/ ><br>Timepoint: Baseline and 4 weeks
- Secondary Outcome Measures
Name Time Method To find out the factors associated with the needs and symptom profile in this patient population as assessed by the variation in the FACT-Leu subscale scores and total scores with respect to sociodemographic and clinical characteristics at baseline and at 4 weeks following induction chemotherapy. <br/ ><br>Timepoint: Baseline and 4 weeks